Indeed, anti-IL5 antibody treatment inhibits the induction of airway subepithelial fibrosis in a murine model of atopic asthma, suggesting a pathogenic role for this cytokine in lung pathology [33]. This evidence concerns the gene IL5 and atopic asthma.